Signaling pathways in tumor vasculogenic mimicry

Area of Science:

• Oncology
• Cancer Biology
• Vascular Biology

Background:

• Tumor growth necessitates a blood supply, traditionally attributed to sprouting angiogenesis.
• Recent research identified vasculogenic mimicry (VM) as an alternative tumor vascularization pathway.
• VM involves aggressive tumor cells forming vessel-like networks, independent of endothelial cells.

Purpose of the Study:

• To review signaling molecules and cascades involved in vasculogenic mimicry (VM).
• To describe the clinical significance of VM in solid tumors.
• To highlight VM's relevance irrespective of anti-angiogenesis treatments.

Main Methods:

• Literature review of studies on tumor vascularization mechanisms.
• Analysis of research on signaling pathways implicated in vasculogenic mimicry.
• Examination of clinical data correlating VM with patient prognosis.

Main Results:

• Vasculogenic mimicry (VM) is a distinct mechanism of tumor vascularization utilized by aggressive cancer cells.
• Several signaling pathways and molecules are identified as crucial for VM formation.
• The presence of VM is a significant indicator of poor prognosis across various cancer types.

Conclusions:

• Vasculogenic mimicry (VM) represents a critical, non-angiogenic pathway for tumor vascularization.
• Understanding VM signaling offers potential therapeutic targets beyond anti-angiogenesis strategies.
• VM's prognostic value underscores its importance in clinical cancer management.